Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-type specific modulation of NMDA receptors triggers antidepressant actions
Santosh Pothula, T. KATO, Rong-Jian Liu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 5097-5111
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Eero Ċastrén, Lisa M. Monteggia
Biological Psychiatry (2021) Vol. 90, Iss. 2, pp. 128-136
Open Access | Times Cited: 348
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Gerard Sanacora, Zhen Yan, Maurizio Popoli
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 86-103
Closed Access | Times Cited: 126
Mechanisms of ketamine and its metabolites as antidepressants
Evan Hess, Lace M. Riggs, Michael Michaelides, et al.
Biochemical Pharmacology (2021) Vol. 197, pp. 114892-114892
Open Access | Times Cited: 116
Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
John H. Krystal, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 41-50
Open Access | Times Cited: 86
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Kyle A. Brown, Todd D. Gould
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1114-1127
Open Access | Times Cited: 16
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
Jiao Wang, Jiayi Lin, Yanfang Deng, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Ajay Sarawagi, Narayan Datt Soni, Anant B. Patel
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 100
Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses
Manoela V. Fogaça, Min Wu, Chan Li, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3277-3291
Open Access | Times Cited: 83
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6713-6713
Open Access | Times Cited: 63
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
Juan Pablo López, Malte Lücken, Elena Brivio, et al.
Neuron (2022) Vol. 110, Iss. 14, pp. 2283-2298.e9
Open Access | Times Cited: 59
Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
Vesna Lazarevic, Yunting Yang, Ivana Flais, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7425-7435
Open Access | Times Cited: 56
Bridging rapid and sustained antidepressant effects of ketamine
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 364-375
Open Access | Times Cited: 34
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Central medial thalamic nucleus dynamically participates in acute itch sensation and chronic itch-induced anxiety-like behavior in male mice
Jiani Li, Xuemei Wu, Liu-Jie Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
John H. Krystal, Alfred P. Kaye, Sarah Jefferson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 30
Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants
Tao Chen, Ling Cheng, Jingwen Ma, et al.
Pharmacological Research (2023) Vol. 194, pp. 106837-106837
Open Access | Times Cited: 24
GluN2A mediates ketamine-induced rapid antidepressant-like responses
Tonghui Su, Yi Lu, Chaoying Fu, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 10, pp. 1751-1761
Closed Access | Times Cited: 24
Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
Allison Carles, Aline Freyssin, Florent Perin-Dureau, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3733-3733
Open Access | Times Cited: 11
Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants
Yating Wang, Ningning Zhang, Lingjie Liu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 594, pp. 46-56
Closed Access | Times Cited: 30
GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology
Yang Ge, Yu Tian Wang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 17
M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses
Manoela V. Fogaça, Min Wu, Chan Li, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 9, pp. 1277-1287
Closed Access | Times Cited: 16
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities
Ryota Shinohara, George K. Aghajanian, Chadi G. Abdallah
Biological Psychiatry (2020) Vol. 90, Iss. 2, pp. 85-95
Closed Access | Times Cited: 44
Update on GPCR-based targets for the development of novel antidepressants
Ioannis Mantas, Marcus Saarinen, Qing Xu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 534-558
Open Access | Times Cited: 36
NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research
Shiyun Lv, Kejie Yao, Youyi Zhang, et al.
Neuropharmacology (2022) Vol. 225, pp. 109378-109378
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top